propidium has been researched along with Cystic Fibrosis in 8 studies
Propidium: Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing." | 5.43 | Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation. ( Audebert, C; Delhaes, L; Deschaght, P; Loywick, A; Merlin, S; Nguyen, LD; Van Daele, S; Vaneechoutte, M; Viscogliosi, E, 2016) |
| "To evaluate the antibacterial and antibiofilm mechanisms of usnic acid (USN) against methicillin-resistant Staphylococcus aureus from cystic fibrosis patients." | 3.83 | Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus. ( Angelucci, S; Barone, L; Crocetta, V; Di Bonaventura, G; Di Giulio, A; Di Giuseppe, F; Di Ilio, C; Pompilio, A; Pomponio, S; Riviello, A; Sulpizio, M, 2016) |
| " Terminal restriction fragment length polymorphism profiling of cystic fibrosis sputum samples was combined with propidium monoazide (PMA) photo-induced cross-linking." | 3.74 | Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections. ( Bruce, KD; Carroll, MP; Daniels, T; Koller, G; Rogers, GB; Stressmann, FA, 2008) |
| "Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing." | 1.43 | Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation. ( Audebert, C; Delhaes, L; Deschaght, P; Loywick, A; Merlin, S; Nguyen, LD; Van Daele, S; Vaneechoutte, M; Viscogliosi, E, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pompilio, A | 1 |
| Riviello, A | 1 |
| Crocetta, V | 1 |
| Di Giuseppe, F | 1 |
| Pomponio, S | 1 |
| Sulpizio, M | 1 |
| Di Ilio, C | 1 |
| Angelucci, S | 1 |
| Barone, L | 1 |
| Di Giulio, A | 1 |
| Di Bonaventura, G | 1 |
| Nguyen, LD | 1 |
| Deschaght, P | 1 |
| Merlin, S | 1 |
| Loywick, A | 1 |
| Audebert, C | 1 |
| Van Daele, S | 1 |
| Viscogliosi, E | 1 |
| Vaneechoutte, M | 1 |
| Delhaes, L | 1 |
| Rogers, GB | 4 |
| Stressmann, FA | 2 |
| Koller, G | 1 |
| Daniels, T | 1 |
| Carroll, MP | 4 |
| Bruce, KD | 4 |
| Marsh, P | 1 |
| Stressmann, AF | 1 |
| Allen, CE | 1 |
| Daniels, TV | 1 |
| Daniels, TW | 1 |
| van der Gast, CJ | 2 |
| Jones, GR | 1 |
| Connett, GJ | 1 |
| Legg, JP | 1 |
| Rüger, M | 1 |
| Bensch, G | 1 |
| Tüngler, R | 1 |
| Reichl, U | 1 |
| Cuthbertson, L | 1 |
| Hoffman, LR | 1 |
| Wing, PA | 1 |
| Pope, C | 1 |
| Hooftman, DA | 1 |
| Lilley, AK | 1 |
| Oliver, A | 1 |
| Cheung, KJ | 1 |
| Li, G | 1 |
| Urban, TA | 1 |
| Goldberg, JB | 1 |
| Griffith, A | 1 |
| Lu, F | 1 |
| Burns, JL | 1 |
8 other studies available for propidium and Cystic Fibrosis
| Article | Year |
|---|---|
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Bacterial Proteins; Benzofurans; Biofilms; Carrier Prote | 2016 |
Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azides; Biodiversity; Cystic Fibrosis; Disease Progression | 2016 |
Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections.
Topics: Adult; Azides; Cell Membrane Permeability; Cross-Linking Reagents; Cystic Fibrosis; DNA, Bacterial; | 2008 |
The exclusion of dead bacterial cells is essential for accurate molecular analysis of clinical samples.
Topics: Adult; Anti-Bacterial Agents; Azides; Cystic Fibrosis; DNA, Bacterial; False Positive Reactions; Gen | 2010 |
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azides; Biodiversity; Cystic Fibrosis; Disease Progression | 2013 |
A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture.
Topics: Bacterial Load; Bacteriological Techniques; Benzothiazoles; Burkholderia cepacia; Burkholderia Infec | 2012 |
Reducing bias in bacterial community analysis of lower respiratory infections.
Topics: Adult; Azides; Bacteria; Cystic Fibrosis; Humans; Propidium; Pseudomonas aeruginosa; Real-Time Polym | 2013 |
Pilus-mediated epithelial cell death in response to infection with Burkholderia cenocepacia.
Topics: Annexin A5; Apoptosis; Blotting, Western; Burkholderia cepacia complex; Burkholderia Infections; Cas | 2007 |